Comparison of the clinical efficacies of two different natural surfactant preparations in neonatal respiratory distress syndrome;Yenidoǧan bebeklerde respiratuvar distres sendromunun tedavisinde iki farkli doǧal surfaktan preparatinin klinik etkinliklerinin karşilaştirilmasi

Cocuk Sagligi ve Hastaliklari Dergisi

Volumn 47, Issue 3, 2004, Pages 161-166

  Sarici, S Ümit ^a,b   Yurdakök, Murat ^a   Naçar, Nazire ^a,c   Korkmaz, Ayşe ^a   Yiǧit, Şule ^a   Tekinalp, Gülsevin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Newborn; Respiratory distress syndrome; Surfactant treatment

Indexed keywords

BERACTANT;

AIRWAY PRESSURE; ARTIFICIAL VENTILATION; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; HUMAN; LUNG HEMODYNAMICS; MAJOR CLINICAL STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OXYGEN CONCENTRATION; PATENT DUCTUS ARTERIOSUS; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; TREATMENT FAILURE;

EID: 4644336799     PISSN: 00100161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membran disease. Am J Dis Child 1959; 96: 517-523.
2. Stark AR, Franta ID. Respiratory distress syndrome. Pediatr Clin North Am 1986; 33: 533-543.
3. Fujiwara T, Maeta H, Chida S, Morita T, Watabe Y, Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet 1980; 1: 55-59.
4. Bassiouny MR, Remo C, Cherian E. Comparison of the changes in the a/A oxygen ratio after administration of two surfactants for the treatment of neonatal respiratory distress syndrome. J Trop Pediatr 1997; 43: 38-41.
5. Modanlau HD, Beharry K, Padilla G, Norris K, Safvati S, Aranda JV. Comparative efficacy of Exosurf and Survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity. J Perinatol 1997; 17: 455-460.
6. Wyble L, Santeiro ML. Costs and outcomes associated with colfosceril versus beractant for the treatment of neonatal respiratory distress syndrome. Ann Pharmacother 1997; 31: 787-788.
7. da Costa DE, Pai MGK, Al Khusaiby SM. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country. Pediatr Pulmonol 1999; 27: 312-317.
8. Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2001; (2): CD0001444.
9. Suresh GK, Soll RF. Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents? Paediatr Drugs 2002; 4: 485-492.
10. Giannakopoulou C, Hatzidaki E, Korakaki E, Christodoulaki M, Margari KM, Mamoulakis D. Comparative randomized study: administration of natural and synthetic surfactant to premature newborns with respiratory distress syndrome. Pediatr Int 2002; 44: 117-121.
11. Speer CP, Gefoller O, Groneck P, et al. Randomized clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Arch Dis Child 1995; 72: F8-F13.
12. Bloom BT, Kattwinkel J, Hall RT, et al. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome. Pediatrics 1997; 100: 31-38.
13. Clark RH, Auten RL, Peabody J. A comparison of the outcomes of neonates treated with two different natural surfactants. J Pediatr 2001; 139: 828-831.
14. Scharf J, Klinge J, Böswald M, et al. Comparison of two bovine surfactant preparations in the treatment of respiratory distress syndrome in prematures. Monatsschr Kinderheilkd 1994; 142: 961-966.
15. Baroutis G, Kaleyias J, Liarou T, Papathoma E, Hatzistamatiou Z, Costalos C. Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur J Pediatr 2003; 162: 476-480.
16. Walti H, Couchard M, Relier JP. Neonatal diagnosis of respiratory distress syndrome. Eur Respir J 1989; 2: 22S-27S.
17. Hjalmarson O. Epidemiology and classification of acute, neonatal respiratory disorders: a prospective study. Acta Paediatr Scand 1981; 70: 773-783.
18. Giedion A, Haefliger H, Dangel P. Acute pulmonary x-ray changes in hyaline membrane disease treated with artificial ventilation and positive end-expiratory pressure (PEP). Pediatr Radiol 1973; 1: 145-152.
19. Horbar JD, Wright LL, Soll RF, et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr 1993; 123: 757-766.
20. Halliday HL. Controversies: synthetic or natural surfactant. The case for natural surfactant. J Perinat Med 1996; 24: 417-426.
21. Halliday HL. Natural vs synthetic surfactants in neonatal respiratory distress syndrome. Drugs 1996; 51: 226-237.